Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Subcutaneous Atezolizumab: A Jab Without a Benefit.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Subcutaneous Atezolizumab: A Jab Without a Benefit.
Subcutaneous Atezolizumab: A Jab Without a Benefit. Clin Pharmacol Drug Dev. 2022 01; 11(1):134-135.
View in:
PubMed
subject areas
Antibodies, Monoclonal, Humanized
Humans
Janus Kinase 2
authors with profiles
Mark J. Ratain